Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Primary candidates include patients with type 2 diabetes and established cardiovascular disease, those with multiple cardiovascular risk factors including dyslipidemia, and adults with obesity or overweight with weight-related comorbidities
The primary difference is that the vials are only available in 2.5 mg and 5 mg doses, while the pens include those doses as well as 7.5 mg, 10 mg, 12.5 mg, and 15 mg. In clinical trials, patients on the 5 mg dose (maximum dose in single-dose vials) lost an average of 15% of their body weight in a year, while those on the 15 mg dose (maximum dose in single-dose pens) lost an average of 20% in a year
The FDA caught an American company making this exact claim in 2007, ordered it to stop, watched it keep selling anyway, and spent nine years pursuing a case that ended in a felony conviction and a lifetime ban for the owner
How BPC-157 Works and Its Benefits for Lyme Disease The BPC-157 peptide is earning attention in functional medicine for its unique ability to support healing across multiple systems affected by Lyme disease, coinfections, and mold toxicity
Panlobular pulmonary emphysema caused by i.v
All our vials arrive in the lyophilized (powdered) form and must be reconstituted with bacteriostatic water prior to research use
US$ 24.70
US$ 24.78
US$ 27.33
US$ 23.22
